Publication Name	World Journal of Gastroenterology
Manuscript ID	18187
Country	South Korea

Received	2015-04-10 08:15
Peer-Review Started	2015-04-10 10:28
To Make the First Decision	2015-05-18 12:28
Return for Revision	2015-05-20 11:09
Revised	2015-06-02 19:42
Second Decision	2015-07-03 21:06
Accepted by Journal Editor-in-Chief	2015-07-04 17:32
Accepted by Company Editor-in-Chief	2015-07-08 17:44
Articles in Press	2015-07-08 17:44
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-08-28 10:19
Publish the Manuscript Online	2015-09-18 10:11

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Randomized Clinical Trial
Article Title	Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication
Manuscript Source	Unsolicited Manuscript
All Author List	Jae Jin Hwang, Dong Ho Lee, Hyuk Yoon, Cheol Min Shin, Young Soo Park and Nayoung Kim
Funding Agency and Grant Number
Corresponding Author	Dong Ho Lee, MD, Department of Internal Medicine, Seoul National University Bundang Hospital, 300 Gumi-dong, Bundang-gu, Seongnam, Gyeonggi-do 463-707, South Korea. dhljohn@yahoo.co.kr
Key Words	Helicobacter pylori; First-line treatment; Eradication; Moxifloxacin; Sequential therapy; Hybrid therapy
Core Tip	To our knowledge, this is the first study to evaluate the efficacy of 14-d treatment with moxifloxacin-based sequential therapy compared with hybrid therapy as a first-line treatment for Helicobacter pylori (H. pylori) infection. Our study shows that moxifloxacin-based sequential therapy is more effective with fewer adverse events compared with hybrid therapy. The high rates of H. pylori eradication and patient compliance with treatment, and low rate of adverse events seen here suggest that moxifloxacin-based sequential therapy is a suitable alternative to standard triple therapy.
Publish Date	2015-09-18 10:11
Citation	Hwang JJ, Lee DH, Yoon H, Shin CM, Park YS, Kim N. Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication. World J Gastroenterol 2015; 21(35): 10234-10241
URL	http://www.wjgnet.com/1007-9327/full/v21/i35/10234.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i35.10234

Full Article (PDF)	WJG-21-10234.pdf
Full Article (Word)	WJG-21-10234.doc
Manuscript File	18187-Review.docx
Answering Reviewers	18187-Answering reviewers.pdf
Audio Core Tip	18187-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	18187-Conflict-of-interest statement.pdf
Copyright License Agreement	18187-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	18187-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	18187-Language certificate.pdf
Peer-review Report	18187-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	18187-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	18187-Scientific misconduct check.pdf
Scientific Editor Work List	18187-Scientific editor work list.pdf